Some drugs make it to clinical trials in humans but are not effective against the ailment involved in the trial. Open the path for such drugs that have been well-tolerated to be used in clinical trials for other ailments. One example of this is Siramesine. It was used in clinical trials for depression, but did not meet with success, even though it was well-tolerated in human subjects (PubMed Autophagy. 2008 May;4(4):487-99. Epub 2008 Feb 22). It targets cancer cells and kills them (PubMed Autophagy. 2008 May;4(4):487-99. Epub 2008 Feb 22). Millions of cancer victims are waiting for your approval of this as a trial drug.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
